Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017

Abstract Background The treatment of choice for substance use disorder (SUD) caused by sedatives, hypnotics, and anxiolytics (SHA) is to slowly taper the dose of the implicated substance to the point of abstinence, thereby minimizing withdrawal symptoms. Concomitant pharmacotherapy may be indicated...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Philipp Pauwels, Beatrice Haack, Sermin Toto, Johanna Seifert, Renate Grohmann, Martin Heinze, Oliver Zolk, Phileas Johannes Proskynitopoulos, Michael Schneider, Timo Greiner
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2025-06-01
Цуврал:	Addiction Science & Clinical Practice
Нөхцлүүд:	Sedatives Hypnotics Anxiolytics Psychotropic drugs Tranquilizing drugs AMSP
Онлайн хандалт:	https://doi.org/10.1186/s13722-025-00579-6
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!